A rare case of nivolumab-related myasthenia gravis and myocarditis in a patient with metastatic gastric cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A rare case of nivolumab-related myasthenia gravis and myocarditis in a patient with metastatic gastric cancer
Authors
Keywords
-
Journal
BMC GASTROENTEROLOGY
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-26
DOI
10.1186/s12876-021-01904-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Japanese gastric cancer treatment guidelines 2018 (5th edition)
- (2020) Gastric Cancer
- Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma
- (2020) Qian Xing et al. Annals of Translational Medicine
- Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors
- (2020) Keitaro Shimozaki et al. Cancer Management and Research
- Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies
- (2019) Annette Johansen et al. NEUROLOGY
- PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis
- (2019) Hayato So et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook
- (2019) Nora Möhn et al. Journal of Clinical Medicine
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia
- (2018) Koutaro Takamatsu et al. Annals of Clinical and Translational Neurology
- Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: A life-threatening continuum of neuromuscular and cardiac toxicity
- (2018) E. Rota et al. CLINICAL NEUROPHYSIOLOGY
- Immune Checkpoint Inhibitor Toxicity in 2018
- (2018) Douglas B. Johnson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors
- (2017) D. Makarious et al. EUROPEAN JOURNAL OF CANCER
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan
- (2017) Shigeaki Suzuki et al. NEUROLOGY
- Myasthenic crisis and polymyositis induced by one dose of nivolumab
- (2016) Toshihiro Kimura et al. CANCER SCIENCE
- Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
- (2016) Lisa Zimmer et al. EUROPEAN JOURNAL OF CANCER
- Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project
- (2015) Megumi Hori et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
- (2009) Shigeaki Suzuki ARCHIVES OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started